Bloom Syndrome (Congenital Telangiectatic Erythema)


Article Author:
Wissem Hafsi


Article Editor:
Talel Badri


Editors In Chief:
Sisira Reddy
Joseph Nahas
CHOKKALINGAM SIVA


Managing Editors:
Avais Raja
Orawan Chaigasame
Khalid Alsayouri
Kyle Blair
Radia Jamil
Erin Hughes
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Navid Mahabadi
Hussain Sajjad
Steve Bhimji
Muhammad Hashmi
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Abbey Smiley
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beenish Sohail
Hajira Basit
Phillip Hynes
Sandeep Sekhon


Updated:
11/8/2019 11:36:13 AM

Introduction

Bloom syndrome, also called Bloom-Torre-Machacek syndrome or congenital telangiectatic erythema (MIM 210900), is a rare autosomal recessive inherited disorder characterized by genomic instability and predisposition to the development all types of cancer. Bloom syndrome is due to mutations in the BLM gene inducing the formation of an abnormal DNA helicase protein. The most prominent features include growth deficiency of prenatal onset, mild immunodeficiency, excessive photosensitivity with facial lupus-like skin lesions, type 2 diabetes mellitus and hypogonadism. The increased risk of malignancy in Bloom syndrome leads to a shortened life expectancy and alters the quality of life of affected persons.[1][2][3]

Etiology

Bloom syndrome is a rare genodermatosis inherited in the autosomal recessive mode. It is due to mutations in the BLM or RECQL3 gene located on chromosome 15 (15q26.1). The parents of a patient with Bloom syndrome may be asymptomatic. The BLM gene encodes a BLM helicase which forms a complex with two other proteins, DNA topoisomerase IIIα and RMI. DNA helicases are involved in the replication and repair of DNA. Thus, the mutation in BLM gene generates errors during the DNA replication process and leads to more numerous chromosomal rearrangements and breakages. Individuals with Bloom syndrome are at high risk of cancer due to the genomic instability. A person with Bloom syndrome might develop up to five independent primary cancers.[4][5][6][7]

Epidemiology

Bloom syndrome is an extremely uncommon disorder in most populations, although its frequency has not been precisely measured. It has been most commonly described in the Ashkenazi Jewish population who account for about one-third of affected individuals worldwide (approximately 1% of Ashkenazi Jews are carriers of the BLMAsh mutation). About 170 cases have been reported in the United States of America. Males are four-fold more affected by Bloom syndrome than females.

Pathophysiology

Mutations in the BLM or RECQL3 gene located on chromosome 15 which encodes a DNA helicase in the RecQ family cause Bloom syndrome. The RecQ family is highly conserved and plays crucial roles as genome caretakers. In humans, mutations in three RecQ genes BLM, RECQL4, and WRN, are responsible for Bloom syndrome, Rothmund-Thomson syndrome, and Werner syndrome, respectively. The protein product of BLM is important in maintaining the stability of the DNA during the replication process. It is involved in the detection, transmission, and resolution of damaged DNA. The lack of BLM protein may cause a change in the divergent epigenetic and genetic anomalies that induce tumor formation.

History and Physical

Persons with Bloom syndrome are characterized by severe prenatal and postnatal growth retardation characterized by proportionate small stature with microcephaly, a characteristic facial morphology including a long, narrow face; a small lower jaw; and prominent nose and ears. A high-pitched voice is also frequently noticed in Bloom syndrome.

They can also present mild immunodeficiency leading to recurrent infections affecting the ears, trachea, bronchi, and lungs during infancy, chronic obstructive pulmonary disease, increased reflux, with vomiting, and diarrhea, type 2 diabetes mellitus, and hypogonadism with azoospermia and infertility in males, and sub-fertility in females.

Cutaneous features include photosensitive erythema on the face in a butterfly distribution over the cheeks similar clinically and histologically to the rash seen in systemic lupus erythematosus. Telangiectasia and poikiloderma occur early in the first or second year of life in response to sun exposure. Similar skin lesions can also present on other areas typically exposed to the sun, such as the forearms and the back of the hands. Also, small clusters of telangiectases often appear in the rash; telangiectases can also affect the eyes. Other skin features include mouth fissures, as well as café-au-lait spots and areas of hypopigmentation which appear on parts of the skin not exposed to the sun, and their development is not in relation with the rashes.

Unlike the Rothmund-Thomson syndrome and Werner syndrome, in which there are cataracts and hair abnormalities, there are no abnormalities of the eyes or hair in Bloom syndrome. There are also no major skeletal or anatomic abnormalities in Bloom syndrome.

Bloom syndrome patients suffer from almost all the major types of cancer, which are characterized by three facts: (1) for each cancer type, tumor development occurs on average at an earlier age than normal, (2) possible occurrence of multiple independent primary cancers, and (3) the types and localization of cancer is very broad. Thus, the mean age of cancer diagnosis is 24 years, and death occurs before 30 years of age. Up to 50% of Bloom syndrome patients will develop cancer, 15% of which are leukemias, 15% lymphomas that occur 150 to 300 times more frequently than in normal individuals. Leukemias may be myeloid or lymphoid malignancies. The median age for leukemia and lymphoma diagnoses is 20 years. Furthermore, 10% of patients will develop a second malignancy. Thus, many types of cancer have been described in Bloom syndromes, such as carcinomas of the respiratory tract, gastrointestinal tract, especially colorectal cancer, breast, liver, skin, connective tissue sarcoma; retinoblastoma and brain tumor. Skin cancers, mainly basal cell carcinoma and squamous cell carcinoma, are also common.

Evaluation

If suspected clinically, the diagnosis of Bloom syndrome should be established by the DNA sequencing which identifies biallelic pathogenic variants in BLM on molecular genetic testing. If the latter is not contributive, specialized cytogenetic studies may highlight an increased frequency of sister chromatid exchange. Genetic and prenatal testing is recommended for high-risk carrier populations.

Treatment / Management

A multidisciplinary approach is required to manage patients with Bloom syndrome. Supplemental feeding does not in improve linear growth. Growth hormone administration to children with Bloom syndrome seems ineffective to increase growth rate or adult height. Furthermore, it may increase the risk to develop tumors. Antibiotic prophylaxis and therapy may control the infections. The treatments used in general population also manage diabetes mellitus. Dermatologic recommendations include frequent skin screenings and avoidance of sun exposure.[8][9]

For the treatment of cancers, the hypersensitivity of cells to both DNA-damaging chemicals and ionizing radiation requires reduction of both dosages and durations to avoid serious complications.

Pearls and Other Issues

A close oncologic following to diagnose early signs of neoplasm is imperative. The tools and the rhythm of supervision are not, however, well codified. Unexplained symptoms may indicate a malignancy, and appropriate investigations should be achieved. Screening for colon and breast cancer earlier and more frequently than in general population is also advised.

Enhancing Healthcare Team Outcomes

Bloom syndrome is a very rare genetic disorder that makes the patient susceptible to many types of cancers. The life expectancy of these patients is markedly reduced and hence palliative care specialists including nurses should be involved early in the course of the disease. With no cure, it is important to ensure that the quality of life is not compromised by excessive testing and surgeries.


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Bloom Syndrome (Congenital Telangiectatic Erythema) - Questions

Take a quiz of the questions on this article.

Take Quiz
Bloom syndrome, chiefly characterized by growth delay, typically displays which cutaneous manifestation?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Telangiectasias confined to the periungual area suggest the diagnosis of which one of the following?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following gene mutations is related to the genesis of Bloom syndrome?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Bloom Syndrome (Congenital Telangiectatic Erythema) - References

References

Gratia M,Rodero MP,Conrad C,Bou Samra E,Maurin M,Rice GI,Duffy D,Revy P,Petit F,Dale RC,Crow YJ,Amor-Gueret M,Manel N, Bloom syndrome protein restrains innate immune sensing of micronuclei by cGAS. The Journal of experimental medicine. 2019 May 6;     [PubMed]
Yin QK,Wang CX,Wang YQ,Guo QL,Zhang ZL,Ou TM,Huang SL,Li D,Wang HG,Tan JH,Chen SB,Huang ZS, Discovery of Isaindigotone Derivatives as Novel Bloom's Syndrome Protein (BLM) Helicase Inhibitors That Disrupt the BLM/DNA Interactions and Regulate the Homologous Recombination Repair. Journal of medicinal chemistry. 2019 Mar 28;     [PubMed]
Flanagan M,Cunniff CM, Bloom Syndrome 1993;     [PubMed]
Velasco-Benítez CA,Ramírez-Hernández CR,Moreno-Gómez JE,Játiva-Mariño E,Zablah R,Rodríguez-Reynosa LL,Leyva-Jiménez SA,Chanís R,Mejía-Castro M, [Overlapping of functional gastrointestinal disorders in latinamerican schoolchildren and adolescents]. Revista chilena de pediatria. 2018 Dec;     [PubMed]
Schierbeck J,Vestergaard T,Bygum A, Skin Cancer Associated Genodermatoses: A Literature Review. Acta dermato-venereologica. 2019 Apr 1;     [PubMed]
Daum H,Meiner V,Hacohen N,Zvi N,Eilat A,Drai-Hasid R,Yagel S,Zenvirt S,Frumkin A, Single nucleotide polymorphism (SNP) based chromosomal microarray analysis provides clues and insights into disease mechanisms. Ultrasound in obstetrics     [PubMed]
Wang H,Li S,Zhang H,Wang Y,Hao S,Wu X, BLM prevents instability of structure-forming DNA sequences at common fragile sites. PLoS genetics. 2018 Nov;     [PubMed]
Aljarad S,Alhamid A,Rahmeh AR,Alibraheem A,Wafa A,Alachkar W,Aljarad Z,Aziz G, Bloom syndrome with myelodysplastic syndrome that was converted into acute myeloid leukaemia, with new ophthalmologic manifestations: the first report from Syria. Oxford medical case reports. 2018 Dec;     [PubMed]
Cunniff C,Djavid AR,Carrubba S,Cohen B,Ellis NA,Levy CF,Jeong S,Lederman HM,Vogiatzi M,Walsh MF,Zauber AG, Health supervision for people with Bloom syndrome. American journal of medical genetics. Part A. 2018 Sep;     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Rheumatology. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Rheumatology, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Rheumatology, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Rheumatology. When it is time for the Rheumatology board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Rheumatology.